Mathematical Approach to Synergistic Management of Bladder Pain Syndrome/Interstitial Cystitis and Vulvodynia: A Case Series Utilizing Principal Component Analysis, Cluster Analysis, and Combination Laser Therapy
- PMID: 39219964
- PMCID: PMC11363212
- DOI: 10.7759/cureus.65829
Mathematical Approach to Synergistic Management of Bladder Pain Syndrome/Interstitial Cystitis and Vulvodynia: A Case Series Utilizing Principal Component Analysis, Cluster Analysis, and Combination Laser Therapy
Abstract
This case series presents three patients with bladder pain syndrome/interstitial cystitis (BPS/IC) and vulvodynia, demonstrating the efficacy of an individualized treatment approach using cluster analysis and combination laser therapy. Principal component analysis (PCA) was used to visualize the dynamic nature of symptom clusters and guide treatment decisions. Case 1 was a 41-year-old woman initially classified as Cluster 1 (PCA coordinates: 1.65, 0.03) transitioned to Cluster 2 (-16.93, -21.75) after bladder hydrodistension. Subsequent Fotona laser (Ljubljana, Slovenia) treatment resulted in the complete resolution of symptoms. Case 2 was a 55-year-old woman, contraindicated for hormone therapy due to breast cancer history, presented as Cluster 2 (PCA coordinates: -24.16, 8.74). Fotona laser treatment shifted her to Cluster 1 (11.22, -20.22), followed by bladder hydrodistension for complete cure. Case 3 was a 49-year-old woman, initially in Cluster 0 (PCA coordinates: 1.892, 30.11), who underwent fulguration for Hunner's lesions. Posttreatment, she moved to Cluster 2 (-24.31, 1.767) and achieved full recovery after Fotona laser therapy. The dynamic nature of symptom clusters, visualized through PCA, guided treatment decisions. The PCA transformation, represented as y =WTz, where z is the standardized symptom vector and W is the principal component matrix, allows for the objective tracking of symptom changes. Combination Fotona laser therapy, including vaginal erbium YAG and neodymium YAG, has proven effective in managing vulvar pain, particularly when hormone therapy is contraindicated. This approach, addressing both urological and gynecological aspects, resulted in sustained symptom improvement for over 12 months in all cases. This case series highlights the synergistic relationship between BPS/IC and vulvodynia, demonstrating the efficacy of comprehensive, adaptive treatment strategies guided by mathematical analysis for complex pelvic pain syndromes.
Keywords: bladder pain syndrome; cluster analysis; interstitial cystitis; laser therapy; synergistic management; vulvodynia.
Copyright © 2024, Okui et al.
Conflict of interest statement
Human subjects: Consent was obtained or waived by all participants in this study. Yokosuka Urogynaecology and Urology Clinic issued approval Approval no. 24-C005. This case report was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from all patients, and written consent was signed by the patients. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Laser Treatment for Patients With Vulvodynia and Interstitial Cystitis/Bladder Pain Syndrome: A Case Series (The UNICORN-3 Study).Cureus. 2023 Jul 12;15(7):e41786. doi: 10.7759/cureus.41786. eCollection 2023 Jul. Cureus. 2023. PMID: 37449291 Free PMC article.
-
Unsupervised Machine Learning Reveals a Vulvodynia-Predominant Subtype in Bladder Pain Syndrome/Interstitial Cystitis.Cureus. 2024 Jun 18;16(6):e62585. doi: 10.7759/cureus.62585. eCollection 2024 Jun. Cureus. 2024. PMID: 39027744 Free PMC article.
-
Is Erbium/Neodymium Laser Combination Therapy an Effective Treatment Option for Interstitial Cystitis/Bladder Pain Syndrome With Vulvodynia?Cureus. 2022 Nov 8;14(11):e31228. doi: 10.7759/cureus.31228. eCollection 2022 Nov. Cureus. 2022. PMID: 36505169 Free PMC article.
-
Gynecological disorders in bladder pain syndrome/interstitial cystitis patients.Int J Urol. 2014 Apr;21 Suppl 1:85-8. doi: 10.1111/iju.12379. Int J Urol. 2014. PMID: 24807511 Review.
-
Non-Hunner's Interstitial Cystitis Is Different from Hunner's Interstitial Cystitis and May Be Curable by Uterosacral Ligament Repair.Urol Int. 2022;106(7):649-657. doi: 10.1159/000524321. Epub 2022 May 5. Urol Int. 2022. PMID: 35512665 Free PMC article. Review.
References
-
- Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. Hanno PM, Erickson D, Moldwin R, Faraday MM. J Urol. 2015;193:1545–1553. - PubMed
-
- Comparison of two different methods for cervicovaginal reconstruction: a long-term follow-up. Liu X, Ding J, Li Y, Hua K, Zhang X. Int Urogynecol J. 2023;34:247–254. - PubMed
-
- Insight into urogynecologic features of women with interstitial cystitis/painful bladder syndrome. Gardella B, Porru D, Ferdeghini F, Martinotti Gabellotti E, Nappi RE, Rovereto B, Spinillo A. Eur Urol. 2008;54:1145–1151. - PubMed
-
- Cure of interstitial cystitis and non-ulcerating Hunner’s ulcer by cardinal/uterosacral ligament repair. Scheffler K, Hakenberg OW, Petros P. Urol Int. 2021;105:920–923. - PubMed
Publication types
LinkOut - more resources
Full Text Sources